Eidos Up 41% Followed by Merger Agreement with BridgeBio worth $2.8 Billion

Eidos stock has made a significant move after the company announced a merger agreement with BridgeBio for a cash and stock deal worth $2.8 billion. Shares of Eidos Therapeutics Inc. (EIDX) have surged above 40% during today’s trading session. The rise in Eidos shares has been driven by the announcement of merger deal with BridgeBio […]